References
- Abel S, Najioullah F, Voluménie JL, Accrombessi L, Carles G, Catherine D, Chiappetta D, Clavel C, Codjo-Sodokine A, El Guedj M, et al.; for HP2V study group. High prevalence of human papillomavirus infection in HIV-infected women living in French Antilles and French Guiana. PLoS One. 2019 Sep 4;14(9): e0221334. https://doi.org/10.1371/journal.pone.0221334
- Aguilar-Lemarroy A, Vallejo-Ruiz V, Cortés-Gutiérrez EI, Salgado-Bernabé ME, Ramos-González NP, Ortega-Cervantes L, Arias-Flores R, Medina-Díaz IM, Hernández-Garza F, Santos-López G, et al.; IMSS Research Network on HPV. Human papillomavirus infections in Mexican women with normal cytology, precancerous lesions, and cervical cancer: type-specific prevalence and HPV coinfections. J Med Virol. 2015 May;87(5):871–884. https://doi.org/10.1002/jmv.24099
- Argyri E, Tsimplaki E, Papatheodorou D, Daskalopoulou D, Panotopoulou E. Recent trends in HPV infection and type distribution in Greece. Anticancer Res. 2018 May;38(5):3079–3084. https://doi.org/10.21873/anticanres.12565
- Bishop B, Dasgupta J, Klein M, Garcea RL, Christensen ND, Zhao R, Chen XS. Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies. J Biol Chem. 2007 Oct;282(43): 31803–31811. https://doi.org/10.1074/jbc.M706380200
- Bruni L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. Human papillomavirus and related diseases in the World. Summary Report. Barcelona (Spain): ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre); 2019 Jan 22.
- Campos RG, Malacara Rosas A, Gutiérrez Santillán E, Delgado Gutiérrez M, Torres Orozco RE, García Martínez ED, Torres Bernal LF, Rosas Cabral A. Unusual prevalence of high-risk genotypes of human papillomavirus in a group of women with neoplastic lesions and cervical cancer from Central Mexico. PLoS One. 2019 Apr 18;14(4):e0215222. https://doi.org/10.1371/journal.pone.0215222
- Canche JC, López IR, Suárez NG, Acosta GC, Conde-Ferráez L, Cetina TC, Losa MRG. High prevalence and low E6 genetic variability of human papillomavirus 58 in women with cervical cancer and precursor lesions in Southeast Mexico. Mem Inst Oswaldo Cruz. 2010 Mar;105(2):144–148. https://doi.org/10.1590/S0074-02762010000200006
- Cardillo M, Hagan R, Abadi J, Abadi MA. CD4 T-cell count, viral load, and squamous intraepithelial lesions in women infected with the human immunodeficiency virus. Cancer. 2001 Apr 25;93(2):111–114. https://doi.org/10.1002/cncr.9016
- Chambuso R, Ramesar R, Kaambo E, Murahwa AT, Abdallah MOE, De Sousa M, Denny L, Williamson AL, Gray CM. Age, absolute CD4 count, and CD4 percentage in relation to HPV infection and the stage of cervical disease in HIV-1-positive women. Medicine (Baltimore). 2020;99(9):e19273. https://doi.org/10.1097/MD.0000000000019273
- Chen Z, Schiffman M, Herrero R, DeSalle R, Anastos K, Segondy M, Sahasrabuddhe VV, Gravitt PE, Hsing AW, Chan PKS, et al. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology. 2018 Mar;516:86–101. https://doi.org/10.1016/j.virol.2018.01.002
- Clifford GM, Gonçalves MAG, Franceschi S; HPV and HIV Study Group. Human papillomavirus types among women infected with HIV: a meta-analysis. AIDS. 2006 Nov 28;20(18):2337–2344. https://doi.org/10.1097/01.aids.0000253361.63578.14
- Clifford GM, Polesel J, Rickenbach M, Dal Maso L, Keiser O, Kofler A, Rapiti E, Levi F, Jundt G, Fisch T, et al.; Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005 Mar 16;97(6):425–432. https://doi.org/10.1093/jnci/dji072
- de Pokomandy A, de Pokomandy A, Lessard B, Mayrand MH, Charest L, Marcus V, Burchell A, Rodrigues-Coutlée S, Coutlée F. Two-years persistence of anal high-risk HPV infections in women living with HIV, results from the EVVA study. Papillomavirus Res. 2018 Jun;5:S12. https://doi.org/10.1016/j.pvr.2018.07.029
- Desruisseau AJ, Schmidt-Grimminger D, Welty E. Epidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa. Infect Dis Obstet Gynecol. 2009;2009:1–6. https://doi.org/10.1155/2009/810596
- Egawa N, Doorbar J. The low-risk papillomaviruses. Virus Res. 2017 Mar;231:119–127. https://doi.org/10.1016/j.virusres.2016.12.017
- Ferré VM, Ekouevi DK, Gbeasor-Komlanvi FA, Collin G, Le Hingrat Q, Tchounga B, Salou M, Descamps D, Charpentier C, Dagnra AC. Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey. Clin Microbiol Infect. 2019 Dec;25(12):1560.e1–1560.e7. https://doi.org/10.1016/j.cmi.2019.04.015
- Frisch M, Biggar RJ, Engels EA, Goedert JJ; AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001 Apr 04;285(13):1736–1745. https://doi.org/10.1001/jama.285.13.1736
- Gallegos-Bolaños J, Rivera-Domínguez JA, Presno-Bernal JM, Cervantes-Villagrana RD. High prevalence of co-infection between human papillomavirus (HPV) 51 and 52 in Mexican population. BMC Cancer. 2017 Dec;17(1):531. https://doi.org/10.1186/s12885-017-3519-7
- Goedert JJ, Coté TR, Virgo P, Scoppa SM, Kingma DW, Gail MH, Jaffe ES, Biggar RJ. Spectrum of AIDS-associated malignant disorders. Lancet. 1998 Jun;351(9119):1833–1839. https://doi.org/10.1016/S0140-6736(97)09028-4
- Gultekin M, Zayifoglu Karaca M, Kucukyildiz I, Dundar S, Boztas G, Semra Turan H, Hacikamiloglu E, Murtuza K, Keskinkilic B, Sencan I. Initial results of population based cervical cancer screening program using HPV testing in one million Turkish women. Int J Cancer. 2018 May 01;142(9):1952–1958. https://doi.org/10.1002/ijc.31212
- Hall TA. Bioedit: a user-friendly biological sequence alignment editor and analysis program for windows 95/98/NT1999. Nucleic Acids Symp Ser. 1999;41:95–98.
- Hanisch RA, Sow PS, Toure M, Dem A, Dembele B, Toure P, Winer RL, Hughes JP, Gottlieb GS, Feng Q, et al.; University of Washington-Dakar HIV and Cervical Cancer Study Group. Influence of HIV-1 and/or HIV-2 infection and CD4 count on cervical HPV DNA detection in women from Senegal, West Africa. J Clin Virol. 2013 Dec;58(4):696–702. https://doi.org/10.1016/j.jcv.2013.10.012
- Jácome-Galarza I, Ito-Nakashimada MA, Figueroa-Aguilar G, García-Latorre E, Salazar MI, López-Orduña E, Camacho AD, Valdez-Alarcón JJ, Hernández JM, León-Avila G. Prevalence of human papillomavirus in women from the State of Michoacan, Mexico, showed high frequency of unusual virus genotypes. Rev Invest Clin. 2017 Sep–Oct;69(5):262–269. https://doi.org/10.24875/RIC.17002065
- Kamps BS, Brodt HR, Staszewski S, Bergmann L, Helm EB. AIDS-free survival and overall survival in HIV infection: the new CDC classification system (1993) for HIV disease and AIDS. Clin Investig. 1994 Mar;72(4):283–287. https://doi.org/10.1007/BF00180041
- Kang M, Cu-Uvin S. Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy. HIV Med. 2012 Jul;13(6):372–378. https://doi.org/10.1111/j.1468-1293.2011.00979.x
- Lazcano-Ponce E, Herrero R, Muñoz N, Cruz A, Shah KV, Alonso P, Hernández P, Salmerón J, Hernández M. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer. 2001 Feb 1;91(3):412–420. https://doi.org/10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M
- Lillo FB, Ferrari D, Veglia F, Origoni M, Grasso MA, Lodini S, Mastrorilli E, Taccagni G, Lazzarin A, Uberti-Foppa C. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis. 2001 Sep;184(5):547–551. https://doi.org/10.1086/322856
- López Rivera MG, Flores MOM, Villalba Magdaleno JDA, Sánchez Monroy V. Prevalence of human papillomavirus in women from Mexico City. Infect Dis Obstet Gynecol. 2012;2012:1–4. https://doi.org/10.1155/2012/384758
- López-Revilla R, Martínez-Contreras LA, Sánchez-Garza M. Prevalence of high-risk human papillomavirus types in Mexican women with cervical intraepithelial neoplasia and invasive carcinoma. Infect Agent Cancer. 2008 Dec;3(1):3. https://doi.org/10.1186/1750-9378-3-3
- Madden T. BLAST Help Manual Overview. In: BLAST® Help [Internet]. Bethesda (USA): National Center for Biotechnology Information; 2008.
- Manos MM. The detection of genital human papillomavirus infection using polymerase chain reaction-reply. JAMA. 1991 Jun 05; 265(21): 2809. https://doi.org/10.1001/jama.1991.03460210055024
- Mayaud P, Gill DK, Weiss HA, Uledi E, Kopwe L, Todd J, ka-Gina G, Grosskurth H, Hayes RJ, Mabey DC, et al. The interrelation of HIV, cervical human papillomavirus, and neoplasia among antenatal clinic attenders in Tanzania. Sex Transm Infect. 2001 Aug 1;77(4):248–254. https://doi.org/10.1136/sti.77.4.248
- Mbulawa ZZA, Coetzee D, Marais DJ, Kamupira M, Zwane E, Allan B, Constant D, Moodley JR, Hoffman M, Williamson AL. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis. 2009 May 15;199(10):1514–1524. https://doi.org/10.1086/598220
- Menon S, Wusiman A, Boily MC, Kariisa M, Mabeya H, Luchters S, Forland F, Rossi R, Callens S, vanden Broeck D. Epidemiology of HPV genotypes among HIV positive women in Kenya: a systematic review and meta-analysis. PLoS One. 2016 Oct 20;11(10):e0163965. https://doi.org/10.1371/journal.pone.0163965
- Montoya Guarín CJ, Moreno Fernández ME, Rugeles López MT. Reacciones y alteraciones del sistema inmune durante la infección por el VIH-1. Infectio. 2006;10(4):250–265.
- Montoya-Fuentes H, Suárez Rincón AE, Ramírez-Muñoz MP, Arévalo-Lagunas I, Morán Moguel MC, Gallegos Arreola MP, Flores-Martínez SE, Rosales Quintana S, Sánchez Corona J. Detección de papilomavirus humano tipos 16, 18, 35 y 58 en cáncer cervicouterino y lesiones escamosas intraepiteliales de alto grado en el occidente de México: correlación clínico-molecular. Ginecol Obstet Mex. 2001 Apr;69(4):137–142.
- Muñoz N, Bosch FX, de Sanjosé S, Shah KV. The role of HPV in the etiology of cervical cancer. Mutat Res Fundam Mol Mech Mutagen. 1994 Mar;305(2):293–301. https://doi.org/10.1016/0027-5107(94)90249-6
- Nayar R, Wilbur DC. The Pap Test and Bethesda 2014. “The reports of my demise have been greatly exaggerated.” (after a quotation from Mark Twain). Acta Cytol. 2015;59(2):121–132. https://doi.org/10.1159/000381842
- Nyasenu YT, Gbeasor-Komlanvi FA, Ehlan A, Issa SAR, Dossim S, Kolou M, Yambiyo BM, Prince-David M, Salou M, Ekouevi DK, et al. Prevalence and distribution of Human Papillomavirus (HPV) genotypes among HIV infected women in Lomé, Togo. PLoS One. 2019 Feb 27;14(2):e0212516. https://doi.org/10.1371/journal.pone.0212516
- Oliveira GR, Siqueira JD, Finger-Jardim F, Vieira VC, Silva RL, Gonçalves CV, Soares EA, Martinez AMB, Soares MA. Characterisation of complete high- and low-risk human papillomavirus genomes isolated from cervical specimens in southern Brazil. Mem Inst Oswaldo Cruz. 2017 Oct;112(10):728–731. https://doi.org/10.1590/0074-02760170121
- Omire A, Budambula NLM, Kirumbi L, Langat H, Kerosi D, Ochieng W, Lwembe R. Cervical dysplasia, infection, and phylogeny of human papillomavirus in HIV-infected and HIV-uninfected women at a Reproductive Health Clinic in Nairobi, Kenya. BioMed Res Int. 2020 Jun 17;2020:1–10. https://doi.org/10.1155/2020/4945608
- Ortega-Cervantes L, Aguilar-Lemarroy A, Rojas-García AE, Barrón-Vivanco BS, Vallejo-Ruiz V, León DC, Hernández YY, Jáuregui-Martínez A, Medina-Díaz IM. Human papilloma virus genotypes in women from Nayarit, Mexico, with squamous intraepithelial lesions and cervical cancer. Int J Health Sci (Qassim). 2016 Jul;10(3):327–338. https://doi.org/10.12816/0048727
- Ortiz AP, Engels EA, Nogueras-González GM, Colón-López V, Soto-Salgado M, Vargas A, Machin M, Shiels MS. Disparities in human papillomavirus-related cancer incidence and survival among human immunodeficiency virus-infected Hispanics living in the United States. Cancer. 2018 Dec;124(23):4520–4528. https://doi.org/10.1002/cncr.31702
- Palefsky J. Human papillomavirus-related disease in people with HIV. Curr Opin HIV AIDS. 2009 Jan;4(1):52–56. https://doi.org/10.1097/COH.0b013e32831a7246
- Peralta-Rodríguez R, Romero-Morelos P, Villegas-Ruíz V, Mendoza-Rodríguez M, Taniguchi-Ponciano K, González-Yebra B, Marrero-Rodríguez D, Salcedo M. Prevalence of human papillomavirus in the cervical epithelium of Mexican women: meta-analysis. Infect Agent Cancer. 2012 Dec;7(1):34. https://doi.org/10.1186/1750-9378-7-34
- Qu W, Jiang G, Cruz Y, Chang CJ, Ho GY, Klein RS, Burk RD. PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems. J Clin Microbiol. 1997 Jun;35(6):1304–1310. https://doi.org/10.1128/jcm.35.6.1304-1310.1997
- Rodrigues LLS, Morgado MG, Sahasrabuddhe VV, De Paula VS, Oliveira NS, Chavez-Juan E, Da Silva DM, Kast WM, Nicol AF, Pilotto JH. Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: high acceptability, hrHPV diversity and risk factors. Gynecol Oncol. 2018 Oct; 151(1):102–110. https://doi.org/10.1016/j.ygyno.2018.08.004
- Roy A, Yang J, Zhang Y. COFACTOR: an accurate comparative algorithm for structure-based protein function annotation. Nucleic Acids Res. 2012 Jul 01;40(W1):W471–W477. https://doi.org/10.1093/nar/gks372
- Sabin CA, Phillips AN. Should HIV therapy be started at a CD4 cell count above 350 cells/μl in asymptomatic HIV-1-infected patients? Curr Opin Infect Dis. 2009 Apr;22(2):191–197. https://doi.org/10.1097/QCO.0b013e328326cd34
- Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JSA, Parham GP. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br J Cancer. 2007 May;96(9):1480–1483. https://doi.org/10.1038/sj.bjc.6603737
- Salcedo M, Pina-Sanchez P, Vallejo-Ruiz V, Monroy-Garcia A, Aguilar-Lemarroy A, Cortes-Gutierrez EI, Santos-Lopez G, Montoya-Fuentes H, Grijalva R, Madrid-Marina V, et al. Human papillomavirus genotypes among females in Mexico: a study from the Mexican institute for social security. Asian Pac J Cancer Prev. 2015 Jan 06;15(23):10061–10066. https://doi.org/10.7314/APJCP.2014.15.23.10061
- Singh DK, Anastos K, Hoover DR, Burk RD, Shi Q, Ngendahayo L, Mutimura E, Cajigas A, Bigirimani V, Cai X, et al. Human papillomavirus infection and cervical cytology in HIV-infected and HIV-uninfected Rwandan women. J Infect Dis. 2009 Jun 15;199(12): 1851–1861. https://doi.org/10.1086/599123
- Sopracordevole F, Campagnutta E, Parin A, Vaccher E, Volpe R, Scarabelli C. Squamous intraepithelial cervical lesions in human immunodeficiency virus-seropositive women. J Reprod Med. 1996 Aug;41(8):586–590.
- Videla S, Darwich L, Cañadas MP, Paredes R, Tarrats A, Castella E, Llatjos M, Bofill M, Clotet B, Sirera G; HIV-HPV Study Group. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology. J Acquir Immune Defic Syndr. 2009 Feb;50(2):168–175. https://doi.org/10.1097/QAI.0b013e3181938e63
- Vyankandondera J, Wambua S, Irungu E, Mandaliya K, Temmerman M, Ryan C, Mohamed Y, Vanden Broeck D, Verhelst R, Chersich MF, et al. Type-specific human papillomavirus prevalence, incident cases, persistence, and associated pregnancy outcomes among HIV-infected women in Kenya. Sex Transm Dis. 2019 Aug; 46(8): 532–539. https://doi.org/10.1097/OLQ.0000000000001029
- WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach – 2010 revision. Geneva (Switzerland): World Health Organization; 2010 [cited 2021 Jul 01]. Available from https://apps.who.int/iris/handle/10665/44379
- WHO. Guidelines for using HIV testing technologies in surveillance: selection, evaluation and implementation – 2009 update. Geneva (Switzerland): World Health Organization; 2009.
- WHO. Human papillomavirus (HPV) and cervical cancer [Internet]. Geneva (Switzerland): World Health Organization; 2020 Nov 11 [cited 2021 Jul 01]. Available from https://www.who.int/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer
- Wu S, Zhang Y. LOMETS: a local meta-threading-server for protein structure prediction. Nucleic Acids Res. 2007;35(10):3375–3382. https://doi.org/10.1093/nar/gkm251
- Xu J, Tan L, Wang T, Cui F, Ding X, Wan Q, Deng D, Chen Z. Genetic variability of human papillomavirus type 51 E6, E7, L1 and L2 genes in Southwest China. Gene. 2019 Mar;690:99–112. https://doi.org/10.1016/j.gene.2018.12.032
- Yamada R, Sasagawa T, Kirumbi LW, Kingoro A, Karanja DK, Kiptoo M, Nakitare GW, Ichimura H, Inoue M. Human papillomavirus infection and cervical abnormalities in Nairobi, Kenya, an area with a high prevalence of human immunodeficiency virus infection. J Med Virol. 2008 May;80(5):847–855. https://doi.org/10.1002/jmv.21170
- Yang J, Zhang Y. I-TASSER server: new development for protein structure and function predictions. Nucleic Acids Res. 2015 Jul 01;43 W1:W174–W181. https://doi.org/10.1093/nar/gkv342